2026-04-02
A Powerful Tool for CAR-T R&D: “Accelerating Development and Reducing Costs” | CD19 CAR-T Off-the-Shelf Lentivirus
Discover how CAR-T evolved from first to fifth generation, understand CAR structure and costimulatory signaling, and explore OBiO Tech’s off‑the‑shelf CD19 CAR‑T lentiviral vectors to accelerate your preclinical immuno‑oncology programs.
Request Now